Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling
Science · 28.02.2025 · 387 (6737)
DOI: 10.1126/science.adp4120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 28.02.2025. Verfasst von Kaixin Ding und 17 weiteren Autor:innen. Beteiligte Einrichtung: HIT Center for Life Sciences, School of Life Science and Technology, State Key Laboratory of Matter Behaviors in Space Environment, Frontier Science …. Hauptthemen laut MEDLINE: AlkB Homolog 5, RNA Demethylase, Glucose, Lipid Metabolism, Liver. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Maintaining glucose and lipid homeostasis is crucial for health, with dysregulation leading to metabolic diseases such as type 2 diabetes mellitus (T2DM) and metabolic dysfunction–associated fatty liver disease (MAFLD). This study identifies alkylation repair homolog protein 5 (ALKBH5), an RNA N 6 -methyladenosine (m 6 A) demethylase, as a major regulator in metabolic disease. ALKBH5 is up-regulated in the liver during obesity and also phosphorylated by protein kinase A, causing its translocation to the cytosol. Hepatocyte-specific deletion of Alkbh5 reduces glucose and lipids by inhibiting the glucagon receptor (GCGR) and mammalian target of rapamycin complex 1 (mTORC1) signaling pathways. Targeted knockdown of hepatic Alkbh5 reverses T2DM and MAFLD in diabetic mice, highlighting its therapeutic potential. This study unveils a regulatory mechanism wherein ALKBH5 orchestrates glucose and lipid homeostasis by integrating the GCGR and mTORC1 pathways, providing insight into the regulation of metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HIT Center for Life Sciences, School of Life Science and Technology, State Key Laboratory of Matter Behaviors in Space Environment, Frontier Science Center for Interaction between Space Environment and Matter, Zhengzhou…
- Department of Cardiology at the First Hospital of Jilin University, Changchun, China.
- NHC Key Laboratory of Cell Transplantation, Department of Hepatic Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, China.
- State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology, and Center for Life Sciences, Peking University, Beijing, China.
- Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou, Chin…
ORCID-Profile: Kaixin Ding, Zhipeng Zhang, Zhengbin Han, Lei Shi, Wenjing Zhou, Yikui Zhao, He Huang, Liwei Xie, Xiao-Wei Chen, Zheng Chen
Zitieren
APA
Ding, K., Zhang, Z., Han, Z., Shi, L., Li, X., Liu, Y., Li, Z., Zhao, C., Cui, Y., Zhou, L., Xu, B., Zhou, W., Zhao, Y., Wang, Z., Huang, H., Xie, L., Chen, X. W., & Chen, Z. (2025). Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling. Science, 387(6737). https://doi.org/10.1126/science.adp4120
Vancouver
Ding K, Zhang Z, Han Z, Shi L, Li X, Liu Y, et al. Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling. Science. 2025;387(6737). doi:10.1126/science.adp4120
BibTeX
@article{Ding2025,
author = {Ding, Kaixin and Zhang, Zhipeng and Han, Zhengbin and Shi, Lei and Li, Xinzhi and Liu, Yutong and Li, Zhenzhi and Zhao, Chongchong and Cui, Yifeng and Zhou, Liying and Xu, Bolin and Zhou, Wenjing and Zhao, Yikui and Wang, Zhiqiang and Huang, He and Xie, Liwei and Chen, Xiao-Wei and Chen, Zheng},
title = {Liver ALKBH5 regulates glucose and lipid homeostasis independently through GCGR and mTORC1 signaling},
journal = {Science},
year = {2025},
volume = {387},
number = {6737},
doi = {10.1126/science.adp4120}
}
EUVIMED